View in EDS PDF Full Text

Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19.
Authors: Jones RS; Eli Lilly and Company, Indianapolis, IN, USA., Smith PS; Eli Lilly and Company, Indianapolis, IN, USA., Berg PH; Eli Lilly and Company, Indianapolis, IN, USA., de la Peña A; Eli Lilly and Company, Indianapolis, IN, USA., Cook PP; East Carolina University Brody School of Medicine, Greenville, NC, USA., Shawa I; Franciscan Alliance, Indianapolis, IN, USA., Kioussopoulos KM; Franciscan Alliance, Indianapolis, IN, USA., Hu Y; Eli Lilly and Company, Indianapolis, IN, USA., Schott RJ; Eli Lilly and Company, Indianapolis, IN, USA.
Source: Clinical medicine insights. Circulatory, respiratory and pulmonary medicine [Clin Med Insights Circ Respir Pulm Med] 2022 Aug 10; Vol. 16, pp. 11795484221119316. Date of Electronic Publication: 2022 Aug 10 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101537753 Publication Model: eCollection Cited Medium: Print ISSN: 1179-5484 (Print) Linking ISSN: 11795484 NLM ISO Abbreviation: Clin Med Insights Circ Respir Pulm Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35991210
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jones+RS%22">Jones RS</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Smith+PS%22">Smith PS</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Berg+PH%22">Berg PH</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22de+la+Peña+A%22">de la Peña A</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Cook+PP%22">Cook PP</searchLink>; East Carolina University Brody School of Medicine, Greenville, NC, USA.<br /><searchLink fieldCode="AU" term="%22Shawa+I%22">Shawa I</searchLink>; Franciscan Alliance, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Kioussopoulos+KM%22">Kioussopoulos KM</searchLink>; Franciscan Alliance, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Hu+Y%22">Hu Y</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Schott+RJ%22">Schott RJ</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101537753%22">Clinical medicine insights. Circulatory, respiratory and pulmonary medicine</searchLink> [Clin Med Insights Circ Respir Pulm Med] 2022 Aug 10; Vol. 16, pp. 11795484221119316. <i>Date of Electronic Publication: </i>2022 Aug 10 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101537753 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1179-5484 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211795484%22">11795484 </searchLink><i>NLM ISO Abbreviation: </i>Clin Med Insights Circ Respir Pulm Med <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35991210
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/11795484221119316
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 11795484221119316
    Titles:
      – TitleFull: Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jones RS
      – PersonEntity:
          Name:
            NameFull: Smith PS
      – PersonEntity:
          Name:
            NameFull: Berg PH
      – PersonEntity:
          Name:
            NameFull: de la Peña A
      – PersonEntity:
          Name:
            NameFull: Cook PP
      – PersonEntity:
          Name:
            NameFull: Shawa I
      – PersonEntity:
          Name:
            NameFull: Kioussopoulos KM
      – PersonEntity:
          Name:
            NameFull: Hu Y
      – PersonEntity:
          Name:
            NameFull: Schott RJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 08
              Text: 2022 Aug 10
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1179-5484
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Clinical medicine insights. Circulatory, respiratory and pulmonary medicine
              Type: main
ResultId 1